These are links to recent news stories that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
General reports from ECTRIMS, a the recent major European conference on MS research, include ocrelizumab, Biotin, Anti-LINGO-1, Lemtrada, genes, teriflunomide and minocycline
MS Trust link: Drugs in development